Abrdn World Healthcare Fund (NYSE:THW) Announces $0.12 Monthly Dividend

Abrdn World Healthcare Fund (NYSE:THW) declared a monthly dividend on Friday, July 10th. Stockholders of record on Thursday, July 23rd will be given a dividend of 0.1167 per share on Friday, July 31st. This represents a c) dividend on an annualized basis and a dividend yield of 10.5%. The ex-dividend date is Thursday, July 23rd.

Abrdn World Healthcare Fund Trading Up 0.4%

Shares of Abrdn World Healthcare Fund stock opened at $13.33 on Tuesday. Abrdn World Healthcare Fund has a 1 year low of $10.14 and a 1 year high of $13.79. The firm’s 50-day moving average is $12.92 and its two-hundred day moving average is $12.62.

Institutional Investors Weigh In On Abrdn World Healthcare Fund

Several institutional investors have recently added to or reduced their stakes in the business. Readystate Asset Management LP purchased a new position in Abrdn World Healthcare Fund during the 4th quarter valued at about $1,939,000. Janney Montgomery Scott LLC grew its position in Abrdn World Healthcare Fund by 59.1% in the 4th quarter. Janney Montgomery Scott LLC now owns 234,266 shares of the company’s stock valued at $2,994,000 after acquiring an additional 87,019 shares in the last quarter. NewEdge Advisors LLC increased its stake in Abrdn World Healthcare Fund by 404.6% during the third quarter. NewEdge Advisors LLC now owns 73,560 shares of the company’s stock worth $927,000 after purchasing an additional 58,983 shares during the period. Raymond James Financial Inc. lifted its position in shares of Abrdn World Healthcare Fund by 28.9% during the third quarter. Raymond James Financial Inc. now owns 193,392 shares of the company’s stock worth $2,437,000 after purchasing an additional 43,376 shares in the last quarter. Finally, TrueMark Investments LLC acquired a new stake in shares of Abrdn World Healthcare Fund during the fourth quarter worth about $524,000.

Abrdn World Healthcare Fund Company Profile

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.